Amisulpride monotherapy in a patient with clozapine-resistant schizophrenia.
Pehlivanidis
Artemios
A
Spyropoulou
Areti C
AC
Tourkantonis
Athanasios
A
Papadimitriou
George N
GN
D000328:Adult; D000077582:Amisulpride; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D018492:Dopamine Antagonists / Q000627:therapeutic use; D065127:Dopamine D2 Receptor Antagonists; D006801:Humans; D008297:Male; D050637:Receptors, Dopamine D3 / Q000037:antagonists & inhibitors; D012559:Schizophrenia / Q000188:drug therapy*; D013469:Sulpiride / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D018492:Dopamine Antagonists; D065127:Dopamine D2 Receptor Antagonists; D050637:Receptors, Dopamine D3; D013469:Sulpiride; D000077582:Amisulpride